技術(shù)文章
Technical articles
更新時(shí)間：2023-05-30
點(diǎn)擊次數(shù)：985
Lab Bioreagents成立于2017年，是一家以創(chuàng)新為導(dǎo)向的生物科技公司，公司專(zhuān)注于不同條件下生物大分子的相互作用研究。通過(guò)人工能AI技術(shù)篩選超過(guò) 2000種化合物，同時(shí)采用動(dòng)態(tài)動(dòng)力學(xué)結(jié)合測(cè)試進(jìn)行優(yōu)化，開(kāi)發(fā)了一系列高品質(zhì)的分析緩沖液和分析試劑盒。Lab Bioreagents產(chǎn)品主要服務(wù)于CRO客戶(hù)，制藥公司、科研機(jī)構(gòu)，客戶(hù)群遍布全球。
Low Binding Buffer
用于降低免疫檢測(cè)中（WB，ELISA，IHC和核酸分析）中非特異性結(jié)合、干擾物質(zhì)的影響，能夠顯著提高檢測(cè)靈敏度和特異性。
StrongBlock buffer
由經(jīng)過(guò)物理預(yù)處理和化學(xué)修飾的酪蛋白和一種專(zhuān)有成分組成用于阻斷微孔板上多余的結(jié)合位點(diǎn)，減少非特異性結(jié)合信號(hào)，提高檢測(cè)靈敏度和特異性
NGB Buffer
由物理預(yù)處理和化學(xué)修飾的BSA、異嗜性阻斷劑和兩種專(zhuān)有成分組成以及0.1M Tris，用于穩(wěn)定蛋白結(jié)合，在樣本酸處理后，提供中和作用。
部分熱銷(xiāo)產(chǎn)品信息
產(chǎn)品名稱(chēng) | 貨號(hào) | 規(guī)格 |
生物基質(zhì) | ||
LowBinding III Buffer | LBA-001-0250 | 250ml |
LowBinding III Buffer | LBA-001-0500 | 500ml |
LowBinding IV Buffer | LBA-002-0250 | 250ml |
LowBinding IV Buffer | LBA-002-0500 | 500ml |
LowBinding V Buffer | LBA-003-0250 | 250ml |
LowBinding V Buffer | LBA-003-0500 | 500ml |
NGB I Buffer I | NGB-001-0100 | 100ML |
NGB I Buffer I | NGB-001-0250 | 250ML |
NGB I Buffer II | NGB-002-0100 | 100ML |
NGB I Buffer II | NGB-002-0250 | 250ML |
NGB I Buffer III | NGB-003-0100 | 100ML |
NGB I Buffer III | NGB-003-0250 | 250ML |
StrongBlock I Buffer | SBA-001-0250 | 250ML |
StrongBlock I Buffer | SBA-001-0500 | 500ML |
StrongBlock II Buffer | SBA-002-0250 | 250ML |
StrongBlock II Buffer | SBA-002-0500 | 500ML |
StrongBlock III Buffer | SBA-003-0250 | 250ML |
StrongBlock III Buffer | SBA-003-0500 | 500ML |
檢測(cè)試劑盒 | ||
Human Adalimumab ELISA Kit | AEK-01-1220 | 96T |
Anti Human Adalimumab antibodies ELISA Kit | AEK-02-1220 | 96T |
Human Alemtuzumab ELISA Kit | AEK-01-1221 | 96T |
Anti Human Alemtuzumab antibodies ELISA Kit | AEK-02-1221 | 96T |
Human Atezolizumab ELISA Kit | AEK-01-1119 | 96T |
Anti Human Atezolizumab antibodies ELISA Kit | AEK-02-1119 | 96T |
Human Infliximab ELISA Kit | IEK-01-1158 | 96T |
Anti Human Infliximab antibodies ELISA Kit | IEK-02-1158 | 96T |
Human Bevacizumab ELISA Kit | BEK-01-1132 | 96T |
Anti Human Bevacizumab antibodies ELISA Kit | BEK-02-1132 | 96T |
Human Natalizumab ELISA Kit | NEK-01-1203 | 96T |
Anti Human Natalizumab antibodies ELISA Kit | NEK-02-1203 | 96T |
Human Omalizumab ELISA Kit | OEK-01-1210 | 96T |
Anti Human Omalizumab antibodies ELISA Kit | OEK-02-1210 | 96T |
Human Trastuzumab ELISA Kit | TEK-01-1125 | 96T |
Anti HumanTrastuzumab antibodies ELISA Kit | TEK-02-1125 | 96T |
Human Pembrolizumab ELISA Kit | PEK-01-1105 | 96T |
Anti Human Pembrolizumab antibodies ELISA Kit | PEK-02-1105 | 96T |
Human Rituximab ELISA Kit | REK-01-1215 | 96T |
Anti Human Rituximab antibodies ELISA Kit | REK-02-1215 | 96T |
當(dāng)前位置：
